EW

#317
Edwards Lifesciences Corporation Common Stock
86.1 5 USD
-1.06%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
85.84
86.72
年范围
72.30
88.28
日变化
-1.06%
每月变动
+5.87%
6个月变化
-0.49%
年变化
+11.26%
前一天收盘价
87.0 7
Open
85.9 7
最低价
85.8 4
High
86.7 2
交易量
716
展开完整图表 完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 49.61 B
  • Employee 16 K
  • Founded N/A
  • CEO -
  • Website www.edwards.com
  • Headquarter Delaware, United States
  • FIGI BBG000BRXP69
  • Industry 医疗器械
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
46.58
市销率
8.26

Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.

新闻